Published in Br Med J on January 09, 1960
Letter: Standardization of the E.S.R. Br Med J (1974) 1.28
Anti-coagulant properties of ethylene bis-iminodiacetic acid. Proc Soc Exp Biol Med (1951) 2.16
The use of a sequestrene-citrate mixture in the estimation of the blood sedimentation rate. J Clin Pathol (1959) 1.71
High-density lipoprotein--the clinical implications of recent studies. N Engl J Med (1989) 5.70
Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys. JAMA (1993) 4.75
Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation (1987) 3.49
Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med (1990) 3.29
The value of lowering cholesterol after myocardial infarction. N Engl J Med (1990) 3.10
Estrogen use and all-cause mortality. Preliminary results from the Lipid Research Clinics Program Follow-Up Study. JAMA (1983) 2.57
Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: data from the Third National Health and Nutrition Examination Survey. Prev Med (1999) 2.32
Change in physician perspective on cholesterol and heart disease. Results from two national surveys. JAMA (1987) 2.17
Cost and health implications of cholesterol lowering. Circulation (1992) 2.00
The Collaborative Lipid Research Clinics Family Study: biological and cultural determinants of familial resemblance for plasma lipids and lipoproteins. Genet Epidemiol (1985) 1.95
The place of HDL in cholesterol management. A perspective from the National Cholesterol Educational Program. Arch Intern Med (1989) 1.87
Lipid Research Clinics Program reference values for hyperlipidemia and hypolipidemia. JAMA (1983) 1.81
A comparison of methods for the estimation of plasma low- and very low-density lipoprotein cholesterol. The Lipid Research Clinics Prevalence Study. JAMA (1986) 1.80
Change in cholesterol awareness and action. Results from national physician and public surveys. Arch Intern Med (1991) 1.75
Changing patterns of cardiovascular disease mortality in the United States. Isr J Med Sci (1982) 1.49
Hypolipidaemia in anaemia. Implications for the epidemiology of ischaemic heart-disease. Lancet (1967) 1.32
Serum cholesterol, diet, and the decline in coronary heart disease mortality. Prev Med (1979) 1.24
Nutrient intakes among selected North American populations in the Lipid Research Clinics Prevalence Study: composition of energy intake. Am J Clin Nutr (1985) 1.23
Relationship between relative body weight and serum lipid levels. Br Med J (1966) 1.23
Neurological dysfunction in two patients receiving captopril and cimetidine. Lancet (1980) 1.20
Treatment of hyperlipidemia. N Engl J Med (1974) 1.15
Chronic Milk-alkali Syndrome with Generalized Osteosclerosis after Prolonged Excessive Intake of "Rennie's" Tablets. Br Med J (1960) 1.14
[Evaluation of clofibrate therapy in peripheral arteriopathy]. Minerva Med (1971) 1.12
Diagnostic value of serum lipids and frequency of lipoprotein patterns in myocardial infarction. J Atheroscler Res (1968) 1.09
Comparison of sodium valproate and phenytoin as single drug treatment in epilepsy. Epilepsia (1981) 1.09
Lipid and lipoprotein distributions in white children ages 6-19 yr. The Lipid Research Clinics Program Prevalence Study. J Chronic Dis (1981) 1.08
Relationships of nutrient intake to lipids and lipoproteins in 1234 white children. The Lipid Research Clinics Prevalence Study. Arteriosclerosis (1983) 1.08
Effect of CPIB ester on plasma free fatty acid levels in man. Metabolism (1966) 1.07
Salivary phenytoin radioimmunoassay. A simple method of the assessment of non-protein bound drug concentrations. Eur J Clin Pharmacol (1977) 1.03
The association of corneal arcus with coronary heart disease and cardiovascular disease mortality in the Lipid Research Clinics Mortality Follow-up Study. Am J Public Health (1990) 1.01
Virus antibody levels in multiple sclerosis. Br Med J (1969) 1.00
Treating high blood cholesterol in the older patient. Am J Cardiol (1989) 0.96
Family aggregation of high density lipoprotein cholesterol. Collaborative lipid research clinics program family study. Arteriosclerosis (1984) 0.95
Biological and cultural sources of familial resemblance in plasma lipids: a comparison between North America and Israel--the Lipid Research Clinics Program. Genet Epidemiol (1988) 0.95
Some difficulties inherent in the interpretation of dietary data from free-living populations. Am J Clin Nutr (1984) 0.91
Cholesterol lowering in the elderly population. Coordinating Committee of the National Cholesterol Education Program. Arch Intern Med (1999) 0.91
Plasma lipids and lipoproteins in adult Jews of different origins: the Jerusalem Lipid Research Clinic prevalence study. Isr J Med Sci (1982) 0.91
Cholesterol and coronary heart disease prevention--a transatlantic consensus. Eur Heart J (1989) 0.88
The Collaborative Lipid Research Clinics Program Family Study. IV. Familial associations of plasma lipids and lipoproteins. Am J Epidemiol (1984) 0.88
Does lowering serum cholesterol levels lower coronary heart disease risk? Endocrinol Metab Clin North Am (1990) 0.88
The association of plasma high-density lipoprotein cholesterol with dietary intake and alcohol consumption. The Lipid Research Clinics Prevalence Study. Circulation (1980) 0.88
Blood lipid levels, thyroid status, and glucose tolerance in progressive partial lipodystrophy. J Clin Pathol (1967) 0.87
Alcohol and high-density lipoprotein cholesterol. Circulation (1981) 0.86
Serum total cholesterol: HDL cholesterol ratios in US white and black adults by selected demographic and socioeconomic variables (HANES II). Am J Public Health (1991) 0.85
Distribution of high density and other lipoproteins in selected LRC prevalence study populations: a brief survey. Lipids (1979) 0.83
Segregation analysis of low levels of high-density lipoprotein cholesterol in the collaborative Lipid Research Clinics Program Family Study. Am J Hum Genet (1987) 0.83
Corneal arcus and hyperlipoproteinaemia. Surv Ophthalmol (1989) 0.83
The Lipid Research Clinics Coronary Primary Prevention Trial: design, results, and implications. Eur J Clin Pharmacol (1991) 0.82
Bilateral internuclear ophthalmoplegia as a false localizing sign. J R Soc Med (1991) 0.82
Study of serum lipid levels in twins. Cardiovasc Res (1968) 0.82
Lipid Research Clinics Coronary Primary Prevention Trial: results and implications. Am J Cardiol (1984) 0.81
When should patients with heterozygous familial hypercholesterolemia be treated? JAMA (1999) 0.81
Genetic factors in lipoprotein variation. Epidemiol Rev (1982) 0.81
Plasma lipids, lipoproteins, and blood pressure in female adolescents using oral contraceptives. J Pediatr (1979) 0.80
The differential diagnosis of nerve compression syndromes in the arm and hand. The neurologist's approach. Hand (1972) 0.80
Cholesterol lowering and the reduction of coronary heart disease risk. JAMA (1986) 0.79
Comparing mean levels of total cholesterol from visit 2 of the Lipid Research Clinics Prevalence Study with the second National Health and Nutrition Examination Survey. Am J Epidemiol (1988) 0.79
Transfer-factor therapy in multiple sclerosis. Lancet (1976) 0.79
Serum lipid levels and body fat distribution in obese females. J Clin Pathol (1967) 0.78
Essential tremor cured by infarction adjacent to the thalamus. J Neurol Neurosurg Psychiatry (1988) 0.78
A double blind trial of acebutolol for migraine prophylaxis. Headache (1978) 0.78
Diagnosis and management of hyperlipoproteinemia in infants and children. Am J Cardiol (1973) 0.78
The Lipid Research Clinics Coronary Primary Prevention Trial. Drugs (1986) 0.77
Does hypolipidemic therapy prevent coronary heart disease? Cardiovasc Clin (1974) 0.77
The plasma lipoproteins. Angiology (1982) 0.77
Treatment of epilepsy with clonazepam and its effect on other anticonvulsants. J Neurol Neurosurg Psychiatry (1977) 0.77
Testing the lipid hypothesis. Clinical trials. Arch Surg (1978) 0.77
A case of hypopituitarism with diabetes insipidus and loss of thirst. Role of antidiuretic hormone and angiotensin II in the control of urine flow and osmolality. J Clin Endocrinol Metab (1975) 0.77
Relation of diet to LDL cholesterol, VLDL cholesterol, and plasma total cholesterol and triglycerides in white adults. The Lipid Research Clinics Prevalence Study. Arteriosclerosis (1983) 0.76
Cholesterol redux. JAMA (1990) 0.75
Relationship of plasma lipids and lipoproteins to obesity. Proc R Soc Med (1966) 0.75
Severe rombergism due to gentamicin toxicity. Br Med J (Clin Res Ed) (1987) 0.75
Of designer drugs, magic bullets, and gold standards. JAMA (1998) 0.75
Population trends in HDL-cholesterol levels. Ann Epidemiol (1998) 0.75
Diet, plasma cholesterol and coronary heart disease. J Nutr (1986) 0.75
Gemfibrozil, lipids, and coronary risk. N Engl J Med (1987) 0.75
Current issues in the design and interpretation of clinical trials. Br Med J (Clin Res Ed) (1985) 0.75
HDL-cholesterol as a negative risk factor. Curr Concepts Nutr (1981) 0.75
Lipoproteins and hyperlipoproteinaemia. Clin Endocrinol Metab (1973) 0.75
Effect of short-term sucrose restriction on serum-lipid levels. Lancet (1966) 0.75
The familial hyperlipoproteinaemias. Scott Med J (1970) 0.75
Anticonvulsant drug concentrations in epileptic patients. Scott Med J (1976) 0.75
Current status of the role of dietary treatment in the prevention and management of coronary heart disease. Med Clin North Am (1979) 0.75
Nutrient--high-density lipoprotein relationships: an overview. Prog Biochem Pharmacol (1983) 0.75
Serum cholesterol and triglyceride levels and adiposity. Cardiovasc Res (1968) 0.75
Clinical aspects of hyperlipoproteinaemia. Biochem Soc Symp (1971) 0.75
3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: a new class of cholesterol-lowering agents. Ann Intern Med (1987) 0.75
Lowering blood cholesterol to reduce coronary heart disease risk. Clin Lab Med (1989) 0.75
The Lipid Research Clinics Coronary Primary Prevention Trial: results and implications. Monogr Atheroscler (1985) 0.75
Parent-offspring aggregation of plasma lipids in selected populations in North America and Israel. The Lipid Research Clinics Prevalence Study. Am J Epidemiol (1987) 0.75
Correlates of low density lipoprotein cholesterol: associations with physical, chemical, dietary, and behavioral characteristics. Arteriosclerosis (1983) 0.75
Stypven time and serum-triglyceride levels in fasting subjects. J Atheroscler Res (1967) 0.75
Cholesterol measurement in children. Am J Dis Child (1993) 0.75
Serum-triglyceride levels and stypven time. Lancet (1966) 0.75
Alterations in clinical chemistry levels associated with the dyslipoproteinemias. The Lipid Research Clinics Program Prevalence Study. Circulation (1986) 0.75
The structure, function and metabolism of high-density lipoproteins: A status report. Circulation (1980) 0.75
The Lipid Research Clinics Primary Prevention Trial and its aftermath. Prog Clin Biol Res (1988) 0.75